On July 10, Pennsylvania-based health and beauty manufacturer A.P. Deauville announced a recall of 67,214 cases of its Power Stick roll-on deodorant due to violations of Current Good Manufacturing ...

According to the recall notice, the Power Stick deodorants were sold nationwide.

FDA warns manufactures of infant ‘drugs’ and bread products about violations By News Desk on July 21, 2025 ...

The FDA has released an “initial batch“ of more than 200 complete response letters (CRLs) in efforts to boost transparency. The attempt may have created more questions, however, with only ...

The manufacturer announced a recall of 67,214 cases of its Power Stick roll-on deodorant due to violations of Current Good Manufacturing Practices.

FDA should judge drugs on what they do in real life, not just in companies’ clinical trials by Aaron Kheriaty, opinion contributor - 07/08/25 7:00 AM ET ...

The FDA has rejected Capricor Therapeutics’ filing for approval of a Duchenne muscular dystrophy (DMD) cell therapy, raising questions about whether the agency's new leadership may be rowing ...

The FDA rejected a Duchenne muscular dystrophy cell therapy from Capricor Therapeutics, as a larger study of the treatment continues.

Insiders tell CNN the FDA’s AI is “hallucinating” studies and can’t access key documents. Agency leaders insist the AI is getting better, and use is not mandatory.

The FDA Just Axed 52 Food Standards – Here's What It Means for Your Groceries With fewer standards in place, the information on your food labels might be less reliable than ever.

FDA's Marty Makary says release of rejection letters will help drugmakers and investors understand decisions behind denials. But there's a big caveat.